Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Eline H. Ploumen"'
Autor:
Tineke H. Pinxterhuis, Eline H. Ploumen, Paolo Zocca, Carine J. M. Doggen, Carl E. Schotborgh, Rutger L. Anthonio, Ariel Roguin, Peter W. Danse, Edouard Benit, Adel Aminian, Marc Hartmann, Gerard C. M. Linssen, Clemens von Birgelen
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 10 (2023)
ObjectivesWe assessed differences in risk profile and 3-year outcome between patients undergoing percutaneous coronary intervention (PCI) for premature and non-premature coronary artery disease (CAD).BackgroundThe prevalence of CAD increases with age
Externí odkaz:
https://doaj.org/article/5bf936d69ec2414aa17f6ea5ca4f4cc3
Autor:
Eline H. Ploumen, Tineke H. Pinxterhuis, Rosaly A. Buiten, Paolo Zocca, Peter W. Danse, Carl E. Schotborgh, Martijn Scholte, R. Melvyn Tjon Joe Gin, Samer Somi, K. Gert van Houwelingen, Martin G. Stoel, H. A. F. de Man, Marc Hartmann, Gerard C. M. Linssen, Liefke C. van der Heijden, Marlies M. Kok, Carine J. M. Doggen, Clemens von Birgelen
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 11, Iss 22 (2022)
Background In a previous trial, higher 5‐year mortality was observed following treatment with biodegradable polymer Orsiro sirolimus‐eluting stents (SES). We assessed 5‐year safety and efficacy of all‐comers as well as patients with diabetes
Externí odkaz:
https://doaj.org/article/c65b5fc2cce445438d8fbe4edbda6f2f
Autor:
Eline H. Ploumen, Tineke H. Pinxterhuis, Paolo Zocca, Ariel Roguin, Rutger L. Anthonio, Carl E. Schotborgh, Edouard Benit, Adel Aminian, Peter W. Danse, Carine J. M. Doggen, Clemens von Birgelen, Marlies M. Kok
Publikováno v:
Cardiovascular Diabetology, Vol 20, Iss 1, Pp 1-11 (2021)
Abstract Background Diabetes is associated with adverse outcomes after percutaneous coronary intervention with drug-eluting stents (DES), but for prediabetes this association has not been definitely established. Furthermore, in patients with prediabe
Externí odkaz:
https://doaj.org/article/cf452734b2a54809b35a85da36d94ffe
Autor:
Tineke H. Pinxterhuis, Eline H. Ploumen, Paolo Zocca, Carine J.M. Doggen, Carl E. Schotborgh, Rutger L. Anthonio, Ariel Roguin, Peter W. Danse, Edouard Benit, Adel Aminian, Martin G. Stoel, Gerard C.M. Linssen, Robert H. Geelkerken, Clemens von Birgelen
Publikováno v:
International journal of cardiology, 374, 27-32. Elsevier
Background: Both patients with obstructive coronary artery disease (CAD) and patients with peripheral arterial disease (PADs) have an increased bleeding risk. Information is scarce on bleeding in CAD patients, treated with percutaneous coronary inter
Autor:
F.R. Halfwerk, Rachèl van der Kolk, Eline H. Ploumen, Clemens von Birgelen, Janine Astrid van Til, Jan G. Grandjean
Publikováno v:
Cardiovascular Revascularization Medicine, 34, 134-139. Elsevier
Purpose International coronary revascularization guidelines recommend both, transradial vascular access for coronary angiography/intervention and use of the radial artery as a conduit for coronary artery bypass grafting (CABG). These recommendations
Autor:
Peter W. Danse, Eline H. Ploumen, Clemens von Birgelen, Adel Aminian, Carl E. Schotborgh, Paolo Zocca, Edouard Benit, Gillian A.J. Jessurun, Rosaly A. Buiten, Carine J.M. Doggen, Ariel Roguin
Publikováno v:
Circulation Journal, 85(11), 1983-1990. Japanese Circulation Society
Background: At 1 year, the international randomized BIONYX trial (ClinicalTrials.gov:NCT02508714) established non-inferiority regarding safety and efficacy of the novel Resolute Onyx zotarolimus-eluting stent (RO-ZES) vs. the Orsiro sirolimus-eluting
Autor:
Marlies M. Kok, Tineke H. Pinxterhuis, Peter W. Danse, Eline H. Ploumen, Clemens von Birgelen, Paolo Zocca, Ariel Roguin, Rutger L. Anthonio, Adel Aminian, Carine J.M. Doggen, Edouard Benit, Carl E. Schotborgh
Publikováno v:
Cardiovascular Diabetology, Vol 20, Iss 1, Pp 1-11 (2021)
Cardiovascular Diabetology
Cardiovascular diabetology, 20(1):217. BioMed Central
Cardiovascular Diabetology
Cardiovascular diabetology, 20(1):217. BioMed Central
Background Diabetes is associated with adverse outcomes after percutaneous coronary intervention with drug-eluting stents (DES), but for prediabetes this association has not been definitely established. Furthermore, in patients with prediabetes treat
Publikováno v:
Cardiovascular Revascularization Medicine, 42, 100-101. Elsevier
Autor:
Eline H. Ploumen, Clemens von Birgelen, Marlies M. Kok, Paolo Zocca, Rosaly A. Buiten, Marc Hartmann, Frits H.A.F. de Man, Martin G. Stoel, Gerard C.M. Linssen, Cees Doelman, Gert D. Kant, K. Gert van Houwelingen, Carine J.M. Doggen
Publikováno v:
Catheterization and cardiovascular interventions, 96(2), E110-E118. Wiley-Liss Inc.
Catheterization and Cardiovascular Interventions
Catheterization and Cardiovascular Interventions
Background Patients with coronary disease may have unknown diabetes or prediabetes. We evaluated 3‐year outcomes after percutaneous coronary intervention (PCI) with contemporary drug‐eluting stents (DES) in patients with silent diabetes, prediabe
Autor:
Paolo Zocca, Edouard Benit, Marc Hartmann, Samer Somi, Eline H. Ploumen, K. Gert van Houwelingen, Carl E. Schotborgh, Ariel Roguin, Carine J.M. Doggen, Peter W. Danse, Rosaly A. Buiten, Alexander R. Schramm, Martin G. Stoel, Gerard C.M. Linssen, Clemens von Birgelen, Adel Aminian, Gillian A.J. Jessurun
Publikováno v:
JACC: Cardiovascular Interventions, 13(9), 1100-1109. Elsevier
Objectives The aim of this study was to assess 2-year safety and efficacy of the current-generation thin composite-wire-strut durable-polymer Resolute Onyx zotarolimus-eluting stent (ZES), compared with the ultrathin-strut biodegradable-polymer Orsir